E
Erin P. Keaney
Researcher at Novartis
Publications - 10
Citations - 825
Erin P. Keaney is an academic researcher from Novartis. The author has contributed to research in topics: Autophagy & PI3K/AKT/mTOR pathway. The author has an hindex of 8, co-authored 9 publications receiving 625 citations.
Papers
More filters
Journal ArticleDOI
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo
William E. Dowdle,Beat Nyfeler,Jane Nagel,Robert Elling,Shanming Liu,Ellen Triantafellow,Suchithra Menon,Zuncai Wang,Ayako Honda,Gwynn Pardee,John Cantwell,Catherine Luu,Ivan Cornella-Taracido,Edmund Harrington,Peter Fekkes,Hong Lei,Qing Fang,Mary Ellen Digan,Debra Burdick,Andrew F. Powers,Stephen B. Helliwell,Simon D’Aquin,Julie Bastien,Henry Wang,Dmitri Wiederschain,Jenny Kuerth,Philip Bergman,David Schwalb,Jason R. Thomas,Savuth Ugwonali,Fred Harbinski,John A. Tallarico,Christine D. Wilson,Vic E. Myer,Jeffery A. Porter,Dirksen E. Bussiere,Peter Finan,Mark Labow,Xiaohong Mao,Lawrence G. Hamann,Brendan D. Manning,Reginald Valdez,Thomas B. Nicholson,Markus Schirle,Mark Knapp,Erin P. Keaney,Leon Murphy +46 more
TL;DR: a4−/− mice exhibit a profound accumulation of iron in splenic macrophages, which are critical for the reutilization of iron from engulfed red blood cells, and a previously unappreciated role for autophagy and NCOA4 in the control of iron homeostasis in vivo is revealed.
Journal ArticleDOI
Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV)
Aurelio Bonavia,Michael Franti,Erin P. Keaney,Kelli Kuhen,Mohindra Seepersaud,Branko Radetich,Jian Shao,Ayako Honda,Janetta Dewhurst,Kara Balabanis,James Monroe,Karen Wolff,Colin P. Osborne,Leanne Lanieri,Keith Hoffmaster,Jakal Amin,Judit Markovits,Michelle Broome,Elizabeth Skuba,Ivan Cornella-Taracido,Gerard Joberty,Tewis Bouwmeester,Lawrence G. Hamann,John A. Tallarico,Tommasi Ruben A,Teresa Compton,Bushell Simon +26 more
TL;DR: A discovery program that includes screen, target identification, validation, and druggability that can be broadly applied to identify and interrogate other host factors for antiviral effect starting from chemical matter of unknown target/mechanism of action is presented.
Journal ArticleDOI
Targeting quiescent leukemic stem cells using second generation autophagy inhibitors
Pablo Baquero,Amy Dawson,Arunima Mukhopadhyay,Elodie M. Kuntz,Rebecca Mitchell,Orianne Olivares,Angela Ianniciello,Mary T. Scott,Karen Dunn,Michael C. Nicastri,Jeffrey D. Winkler,Alison M. Michie,Kevin M. Ryan,Christina Halsey,Eyal Gottlieb,Erin P. Keaney,Leon Murphy,Ravi K. Amaravadi,Tessa L. Holyoake,G. Vignir Helgason +19 more
TL;DR: It is presented that while HCQ is ineffective, Lys05-mediated autophagy inhibition reduces LSCs quiescence and drives myeloid cell expansion, providing a strong rationale for clinical use of second generation autophagic inhibitors as a novel treatment for CML patients with LSC persistence.
Journal ArticleDOI
Vps34 PI 3-kinase inactivation enhances insulin sensitivity through reprogramming of mitochondrial metabolism
Benoit Bilanges,Samira Alliouachene,Wayne Pearce,Daniele Morelli,Gyorgy Szabadkai,Yuen-Li Chung,Gaëtan Chicanne,Colin Valet,Hill Jm,Voshol Pj,Lucy M. Collinson,Christopher J. Peddie,Khaled Ali,Essam Ghazaly,Rajeeve,Georgios Trichas,Shankar Srinivas,Claire Chaussade,Rachel S. Salamon,Jonathan M. Backer,Cheryl L. Scudamore,Maria A. Whitehead,Erin P. Keaney,Leon Murphy,Robert K. Semple,Bernard Payrastre,Sharon A. Tooze,Bart Vanhaesebroeck +27 more
TL;DR: Ionia Bilanges et al. show that inhibition of this kinase in mice improves glucose tolerance and diet-induced steatosis by modulating mitochondrial respiration and metabolism.
Journal ArticleDOI
Potent, Selective, and Orally Bioavailable Inhibitors of VPS34 Provide Chemical Tools to Modulate Autophagy in Vivo
Ayako Honda,Edmund Harrington,Ivan Cornella-Taracido,Pascal Furet,Mark Knapp,Meir Glick,Ellen Triantafellow,William E. Dowdle,Dmitri Wiedershain,Wieslawa Maniara,Christine Moore,Peter Finan,Lawrence G. Hamann,Brant Firestone,Leon Murphy,Erin P. Keaney +15 more
TL;DR: The discovery of potent and selective VPS34 inhibitors, their pharmacokinetic (PK) properties, and ability to inhibit autophagy in cellular and mouse models are described.